Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematologic Toxicity Observation of the TPF Medical Protocol. Description of the Impact of Febrile Neutropenia in Patients Who Receive the Chemotherapy of the TPF Medical Protocol in Head and Neck Cell Carcinoma

NCT01268878 is registered in ClinicalTrials.gov with Groupe Oncologie Radiotherapie Tete et Cou as lead sponsor.

NCT NCT01268878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01268878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematologic Toxicity Observation of the TPF Medical Protocol. Description of the Impact of Febrile Neutropenia in Patients Who Receive the Chemotherapy of the TPF Medical Protocol in Head and Neck Cell Carcinoma
Lead sponsor
Groupe Oncologie Radiotherapie Tete et Cou
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2011
Enrollment
130 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell head and neck carcinoma